Autoimmune polyglandular syndrome type 2 shows the same HLA class II pattern as type 1 diabetes

Tissue Antigens

Volumn 77, Issue 4, 2011, Pages 317-324

  Weinstock, C ^a   Matheis, N ^b   Barkia, S ^b   Haager, M C ^b   Janson, A ^a   Markovic A ^a   Bux, J ^a   Kahaly, G J ^b  

^a German Red Cross Blood Service West   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Autoimmune polyglandular syndrome type 2; Disease association; DQA1; DQB1; DRB1; Human leukocyte antigen class II; Type 1 diabetes

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ALLELES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; HLA-D ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 79952398727     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01634.x     Document Type: Article

References (40)

1. Michels AW, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol 2010: 125: S226-37.
2. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004: 350: 2068-79.
3. Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009: 161: 11-20.
4. Husebye ES, Anderson MS. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. Immunity 2010: 32: 479-87.
5. Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J Clin Endocrinol Metab 2009: 94: 5117-24.
6. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007: 179: 4704-10.
7. Siminovitch KA. PTPN22 and autoimmune disease. Nat Genet 2004: 36: 1248-9.
8. Smyth DJ, Cooper JD, Howson JM et al. PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes. Diabetes 2008: 57: 1730-7.
9. Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian diabetes registry. Hum Mol Genet 1996: 5: 1075-80.
10. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003: 423: 506-11.
11. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984: 33: 176-83.
12. Lowe CE, Cooper JD, Brusko T et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 2007: 39: 1074-82.
13. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009: 360: 1646-54.
14. Nerup J, Platz P, Andersen OO et al. HL-A antigens and diabetes mellitus. Lancet 1974: 2: 864-6.
15. Concannon P, Erlich HA, Julier C et al. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1, 435 multiplex families. Diabetes 2005: 54: 2995-3001.
16. Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 2008: 29: 697-725.
17. Heward JM, Allahabadia A, Daykin J et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 1998: 83: 3394-7.
18. Eisenbarth G, Wilson P, Ward F, Lebovitz HE. HLA type and occurrence of disease in familial polyglandular failure. N Engl J Med 1978: 298: 92-4.
19. Baker PR, Baschal EE, Fain PR et al. Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J Clin Endocrinol Metab 2010: 95: E263-70.
20. Triolo TM, Baschal EE, Armstrong TK et al. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. J Clin Endocrinol Metab 2009: 94: 4517-23.
21. Yu L, Brewer KW, Gates S et al. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999: 84: 328-35.
22. Dittmar M, Ide M, Wurm M, Kahaly GJ. Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur J Endocrinol 2008: 159: 55-60.
23. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab 2003: 88: 2983-92.
24. Dittmar M, Kaczmarczyk A, Bischofs C, Kahaly GJ. The proinflammatory cytokine TNF-alpha -308 AA genotype is associated with polyglandular autoimmunity. Immunol Invest 2009: 38: 255-67.
25. Ferencik S, Grosse-Wilde H. Caucasian German normal. In: Terasaki PI, Gjertson DW, eds. HLA, 1997. Los Angeles: UCLA Tissue Typing Laboratory, 1997: 222-3.
26. Doherty DG, Vaughan RW, Donaldson PT, Mowat AP. HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids. Hum Immunol 1992: 34: 53-63.
27. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007: 68: 779-88.
28. a web-based HLA haplotype calculator for improved donor selection and quality control. Accessed October 2010.
29. Langö A, Lindblom B. HLA DQA-DQB haplotypes in a Swedish population. Eur J Immunogenet 1993: 20: 453-60.
30. Wallaschofski H, Meyer A, Tuschy U, Lohmann T. HLA-DQA1*031101-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res 2003: 35: 120-4.
31. Huang W, Connor E, Rosa TD et al. Although DR3-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J Clin Endocrinol Metab 1996: 81: 2559-63.
32. Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 2005: 90: 4904-11.
33. Thomson G, Valdes AM, Noble JA et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007: 70: 110-27.
34. Petrone A, Bugawan TL, Mesturino CA et al. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens 2001: 58: 385-94.
35. Santamaria P, Barbosa JJ, Lindstrom AL, Lemke TA, Goetz FC, Rich SS. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetic patients. J Clin Endocrinol Metab 1994: 78: 878-83.
36. Moens H, Farid NR, Sampson L, Noel EP, Barnard JM. Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med 1978: 299: 133-4.
37. Petrone A, Giorgi G, Mesturino CA et al. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 2001: 11: 171-5.
38. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 1992: 74: 496-503.
39. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 1999: 84: 4656-64.
40. Miao D, Yu L, Eisenbarth GS. Role of autoantibodies in type 1 diabetes. Front Biosci 2007: 12: 1889-98.